. . . . . . . "[Our results suggest that patients with HER2(+) breast cancer may benefit from anti-TBK1/IKK? plus anti-HER2 combination therapies and establish conditions that can be used to screen for additional TIC-specific inhibitors of HER2(+) breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:17:48+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .